Enacts R.S. 17:436.1(N) to require the governing authority of each public
elementary and secondary school to adopt a policy to maintain a supply of
auto-injectable Epinephrine in a secure location in each classroom
assigned to a student who is deemed by his physician to be at high risk
for anaphylactic reaction and incapable of self-administration of
auto-injectable Epinephrine. Such policy shall require the student’s
parent or legal guardian to annually provide the school with the supply of
Epinephrine, written certification from the student’s licensed medical
physician that the student is at high risk of having anaphylaxis, written
authorization for the student to be administered the medication, and a
treatment plan from the student’s licensed medical physician for managing
anaphylactic episodes. The governing authority of the public elementary
and secondary school shall inform the parent or legal guardian of the
student in writing that the school and its employees shall incur no
liability as a result of any injuries sustained by the student from the
good faith administration of auto-injectable Epinephrine. The parent or
legal guardian shall sign a statement acknowledging that the school shall
incur no liability and that the parent or legal guardian shall indemnify
and hold harmless the school and its employees against any claims that may
arise relating to the good faith administration of auto-injectable
Epinephrine. Each school shall include the policy required by this statute
in its student handbook and shall post it on the school’s website if it
has one. [Effective 6/10/22].
